With the discovery of the intrinsic enzyme‐like activity of metal oxides, nanozymes garner
significant attention due to their superior characteristics, such as low cost, high stability, multi …

The COVID-19 pandemic caused by SARS-CoV-2 has been identified as a culprit in the
development of a variety of disorders, including arthritis. Although the emergence of arthritis …

Osteoarthritis (OA) is one of the leading causes of chronic disability in the elderly. Effective
clinical interventions for OA are still lacking, and new therapeutic measures are urgently …

There is an urgent medical need to develop effective therapies that can ameliorate damage
to the radiation-exposed hematopoietic system. Nanozymes with robust antioxidant …

Osteoarthritis (OA) is induced by matrix degradation and inflammation mediated by bromo-
domain-containing protein 4 (BRD4)-dependent catabolic factors. BRD4 acts as both a …

The recovery of infectious wound tissues presents a significant global health challenge due
to the impediments posed by the harsh healing microenvironment, which includes ongoing …

Atom engineering has been demonstrated to be an efficient strategy for optimizing the
activities of Prussian blue analogue (PBA)-based nanozymes. Herein, using a series of …

Oxidative stress and dysregulated inflammatory responses are the hallmarks of inflammatory
disorders, which are key contributors to high mortality rates and impose a substantial …

Osteoarthritis (OA) is a progressive joint disorder characterized by sustained oxidative
stress, chronic inflammation, and the degradation of cartilage. Despite extensive research …